Novo Nordisk As Stock Today
| NONOF Stock | USD 122.81 1.34 1.08% |
Performance8 of 100
| Odds Of DistressLess than 9
|
Novo Nordisk is trading at 122.81 as of the 18th of April 2024. This is a -1.08 percent decrease since the beginning of the trading day. The stock's lowest day price was 122.8. Novo Nordisk has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. Equity ratings for Novo Nordisk AS are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of March 2024 and ending today, the 18th of April 2024. Click here to learn more.
Novo Nordisk AS, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. NOVO NORDISK is traded on OTC Exchange in the United States. The company has 1.72 B outstanding shares. More on Novo Nordisk AS
Moving together with Novo Pink Sheet
| 0.99 | NVO | Novo Nordisk AS Financial Report 2nd of May 2024 | PairCorr |
Moving against Novo Pink Sheet
| 0.81 | ZTLLF | Zonetail | PairCorr |
| 0.79 | WXIBF | WuXi Biologics | PairCorr |
| 0.66 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |
| 0.51 | CSLLY | CSL | PairCorr |
| 0.5 | CMXHF | CSL Limited | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Novo Pink Sheet Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Novo Nordisk's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Novo Nordisk or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Lars Soerensen |
| Old Name | Novo Nordisk A/S B |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Novo Nordisk AS [NONOF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Mega-Cap' category with a current market capitalization of 318.05 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Novo Nordisk's market, we take the total number of its shares issued and multiply it by Novo Nordisk's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Novo Nordisk AS classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 1.72 B outstanding shares.
Novo Nordisk AS has accumulated about 31.04 B in cash with 78.89 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.68.
Check Novo Nordisk Probability Of Bankruptcy
Ownership AllocationNovo Nordisk AS maintains a total of 1.72 Billion outstanding shares. 30% of Novo Nordisk outstanding shares are owned by institutional investors. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Novo Ownership Details
Novo Stock Price Odds Analysis
In reference to a normal probability distribution, the odds of Novo Nordisk jumping above the current price in 90 days from now is about 44.62%. The Novo Nordisk AS probability density function shows the probability of Novo Nordisk pink sheet to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Novo Nordisk has a beta of 0.4554. This indicates as returns on the market go up, Novo Nordisk average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Novo Nordisk AS will be expected to be much smaller as well. Additionally, novo Nordisk AS has an alpha of 0.2216, implying that it can generate a 0.22 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Novo Nordisk to move above the current price in 90 days from now is about 44.62 (This Novo Nordisk AS probability density function shows the probability of Novo Pink Sheet to fall within a particular range of prices over 90 days) .
Novo Nordisk AS Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Novo Nordisk market risk premium is the additional return an investor will receive from holding Novo Nordisk long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Novo Nordisk. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Novo Nordisk's alpha and beta are two of the key measurements used to evaluate Novo Nordisk's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.64 | |||
| Semi Deviation | 1.26 | |||
| Standard Deviation | 2.24 | |||
| Variance | 5.01 |
Novo Stock Against Markets
Picking the right benchmark for Novo Nordisk pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Novo Nordisk pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Novo Nordisk is critical whether you are bullish or bearish towards Novo Nordisk AS at a given time. Please also check how Novo Nordisk's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Novo Nordisk without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
| All Next | Launch Module |
Novo Nordisk Corporate Directors
Novo Nordisk corporate directors refer to members of a Novo Nordisk board of directors. The board of directors generally takes responsibility for the Novo Nordisk's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Novo Nordisk's board members must vote for the resolution. The Novo Nordisk board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Soeren Pedersen | Director, Employee Representative | Profile | |
| Kasim Kutay | Director | Profile | |
| Sylvie Gregoire | Director | Profile | |
| Mette Jensen | Director, Employee Representative | Profile |
How to buy Novo Pink Sheet?
Before investing in Novo Nordisk, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Novo Nordisk. To buy Novo Nordisk stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Novo Nordisk. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Novo Nordisk stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Novo Nordisk AS stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Novo Nordisk AS stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Novo Nordisk AS, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Novo Pink Sheet please use our How to Invest in Novo Nordisk guide.
Already Invested in Novo Nordisk AS?
The danger of trading Novo Nordisk AS is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Novo Nordisk is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Novo Nordisk. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Novo Nordisk AS is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Novo Nordisk AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Novo Nordisk's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novo Nordisk As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novo Nordisk As Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novo Nordisk AS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Novo Pink Sheet analysis
When running Novo Nordisk's price analysis, check to measure Novo Nordisk's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Nordisk is operating at the current time. Most of Novo Nordisk's value examination focuses on studying past and present price action to predict the probability of Novo Nordisk's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Nordisk's price. Additionally, you may evaluate how the addition of Novo Nordisk to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |